KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
We investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restric...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/8/355 |
id |
doaj-a7511ae58f204f4f976e1e5c55ef373d |
---|---|
record_format |
Article |
spelling |
doaj-a7511ae58f204f4f976e1e5c55ef373d2020-11-24T21:25:12ZengMDPI AGBiomolecules2218-273X2019-08-019835510.3390/biom9080355biom9080355KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid ArthritisAgnieszka Paradowska-Gorycka0Barbara Stypinska1Andrzej Pawlik2Damian Malinowski3Katarzyna Romanowska-Prochnicka4Malgorzata Manczak5Marzena Olesinska6Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, PolandDepartment of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, PolandDepartment of Physiology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Pharmacology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Gerontology and Health Promotion, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandWe investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method and for rs2305948 and rs2071559 KDR single nucleotide polymorphisms (SNPs) by TaqMan SNP genotyping assay. KDR serum levels were determined by enzyme-linked immunosorbent assay (ELISA). The rs1870377 KDR variant has shown association with RA under the codominant (<i>p</i> = 0.02, OR = 1.76, 95% CI = 1.09−2.85) and recessive models (<i>p</i> = 0.019, OR = 1.53, 95% CI = 1.07−2.20). KDR rs2305948 was associated with RA under the dominant model (<i>p</i> = 0.005, OR = 1.38, 95% CI = 1.10−1.73). Under the codominant model, the frequency of the rs2071559 TC and GG genotypes were lower in RA patients than in controls (<i>p</i> < 0.001, OR = 0.51, 95% CI = 0.37−0.69, and <i>p</i> = 0.002, OR = 0.57, 95% CI = 0.39−0.81). KDR rs2071559 T and rs2305948 A alleles were associated with RA (<i>p</i> = 0.001, OR = 0.60, 95% CI = 0.45−0.81 and <i>p</i> = 0.008, OR = 1.71, CI = 1.15−2.54). KDR rs2305948SNP was associated with Disease Activity Score (DAS)-28 score (<i>p</i> < 0.001), Visual Analog Scale (VAS) score (<i>p</i> < 0.001), number of swollen joints (<i>p</i> < 0.001), mean value of CRP (<i>p</i> < 0.001). A higher KDR serum level was found in RA patients than in HC (8018 pg/mL versus 7381 pg/mL, <i>p</i> = 0.002). Present results shed light on the role of KDR genetic variants in the severity of RA.https://www.mdpi.com/2218-273X/9/8/355angiogenesisinflammationgene polymorphismsKDRrheumatoid arthritisprotein level |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Agnieszka Paradowska-Gorycka Barbara Stypinska Andrzej Pawlik Damian Malinowski Katarzyna Romanowska-Prochnicka Malgorzata Manczak Marzena Olesinska |
spellingShingle |
Agnieszka Paradowska-Gorycka Barbara Stypinska Andrzej Pawlik Damian Malinowski Katarzyna Romanowska-Prochnicka Malgorzata Manczak Marzena Olesinska KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis Biomolecules angiogenesis inflammation gene polymorphisms KDR rheumatoid arthritis protein level |
author_facet |
Agnieszka Paradowska-Gorycka Barbara Stypinska Andrzej Pawlik Damian Malinowski Katarzyna Romanowska-Prochnicka Malgorzata Manczak Marzena Olesinska |
author_sort |
Agnieszka Paradowska-Gorycka |
title |
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
title_short |
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
title_full |
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
title_fullStr |
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
title_full_unstemmed |
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis |
title_sort |
kdr (vegfr2) genetic variants and serum levels in patients with rheumatoid arthritis |
publisher |
MDPI AG |
series |
Biomolecules |
issn |
2218-273X |
publishDate |
2019-08-01 |
description |
We investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method and for rs2305948 and rs2071559 KDR single nucleotide polymorphisms (SNPs) by TaqMan SNP genotyping assay. KDR serum levels were determined by enzyme-linked immunosorbent assay (ELISA). The rs1870377 KDR variant has shown association with RA under the codominant (<i>p</i> = 0.02, OR = 1.76, 95% CI = 1.09−2.85) and recessive models (<i>p</i> = 0.019, OR = 1.53, 95% CI = 1.07−2.20). KDR rs2305948 was associated with RA under the dominant model (<i>p</i> = 0.005, OR = 1.38, 95% CI = 1.10−1.73). Under the codominant model, the frequency of the rs2071559 TC and GG genotypes were lower in RA patients than in controls (<i>p</i> < 0.001, OR = 0.51, 95% CI = 0.37−0.69, and <i>p</i> = 0.002, OR = 0.57, 95% CI = 0.39−0.81). KDR rs2071559 T and rs2305948 A alleles were associated with RA (<i>p</i> = 0.001, OR = 0.60, 95% CI = 0.45−0.81 and <i>p</i> = 0.008, OR = 1.71, CI = 1.15−2.54). KDR rs2305948SNP was associated with Disease Activity Score (DAS)-28 score (<i>p</i> < 0.001), Visual Analog Scale (VAS) score (<i>p</i> < 0.001), number of swollen joints (<i>p</i> < 0.001), mean value of CRP (<i>p</i> < 0.001). A higher KDR serum level was found in RA patients than in HC (8018 pg/mL versus 7381 pg/mL, <i>p</i> = 0.002). Present results shed light on the role of KDR genetic variants in the severity of RA. |
topic |
angiogenesis inflammation gene polymorphisms KDR rheumatoid arthritis protein level |
url |
https://www.mdpi.com/2218-273X/9/8/355 |
work_keys_str_mv |
AT agnieszkaparadowskagorycka kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT barbarastypinska kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT andrzejpawlik kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT damianmalinowski kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT katarzynaromanowskaprochnicka kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT malgorzatamanczak kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis AT marzenaolesinska kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis |
_version_ |
1725984160926924800 |